Just the Facts on UDR, Inc. (UDR)

UDR, Inc. (UDR) is an interesting player in the Financial space, with a focus on REIT – Residential. The stock has been active on the tape, currently trading at $35.75, down from yesterday’s close by -0.11%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

UDR, Inc. (UDR) currently trades with a market capitalization of $9.67 Billion. That value represents a market adjusting for revenues that have been growing by 4.06 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of $260.8 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $0.05 on a per share basis this quarter. Perhaps, that suggests something about why 2.10% of the outstanding share supply is held by institutional investors.



Technical Analysis

It’s important to check the technicals to get a sense of how UDR has been acting. Looking at the stock’s movement on the chart, UDR, Inc. recorded a 52-week high of $40.71. It is now trading 4.96% off that level. The stock is trading $34.73 its 50-day moving average by -1.02%. The stock carved out a 52-week low down at $32.88.

In recent action, UDR, Inc. (UDR) has made a move of +0.96% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 14.08, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 2.16% with $265.16 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of UDR.

SHARE
Previous articleThe Case for and Against Allscripts Healthcare Solutions, Inc. (MDRX)
Next articleTaking a Look at the Data Behind Archer-Daniels-Midland Company (ADM)